| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/16/2008 | EP1910524A1 Modulation of sphingosine kinase signalling |
| 04/16/2008 | EP1910353A1 Tricyclic delta- opioid modulators |
| 04/16/2008 | EP1910342A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 04/16/2008 | EP1910292A1 Piperidine derivative as tachykinin receptor antagonist |
| 04/16/2008 | EP1910275A2 Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field |
| 04/16/2008 | EP1909788A2 Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| 04/16/2008 | EP1909781A1 Therapeutic combination comprising a nmda receptors blocker and a narcotic analgesic substance |
| 04/16/2008 | EP1423382B1 Pyrazole-derived kinase inhibitors and uses thereof |
| 04/16/2008 | EP1250155B1 Angiogenesis and vascular permeability modulators and inhibitors |
| 04/16/2008 | EP1108039B1 Elongase genes and uses thereof |
| 04/16/2008 | EP0984023B9 Cell surface molecule mediating cell adhesion and signal transmission |
| 04/16/2008 | CN101163683A 4-0x0quinaz0lin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 04/16/2008 | CN101163668A Calcium bis [ (2s) - 3- [3-[ (2s) -3- (4-chloro-2-cyanophenoxy) -2- fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN101161281A A Chinese medicine liniment for treating cervical spondylosis, lumbar disease and its preparing method |
| 04/16/2008 | CN101161261A A Chinese medicine for treating osteoproliferation rheumatalgia |
| 04/16/2008 | CN101161251A On-off total saponin as well as its extracting method and application |
| 04/16/2008 | CN101161091A An antierythrite chewing gum |
| 04/16/2008 | CN100381454C Crystalline form of a ribofuranosyluronamide derivative: a human adenosine a2a receptor agonist |
| 04/16/2008 | CN100381437C Compounds, compositions and methods |
| 04/16/2008 | CN100381435C Extractive of general flavone from blackberry lily, preparation method and application in preparing medication |
| 04/16/2008 | CN100381428C Quinazolone and quinazolone compound and application thereof |
| 04/16/2008 | CN100381425C 6-amino-1H-indazole and its pharmaceutical compositions as phosphodiesterase 4 inhibitors, and use thereof |
| 04/16/2008 | CN100381424C Biaryl sulfonamides and methods for using same |
| 04/16/2008 | CN100381140C Medicine for treating rheumatic disease, rheumatoid disease and other diseases and its preparing method |
| 04/16/2008 | CN100381128C Inclusion compound of ants supercritical extracts and preparation process thereof |
| 04/15/2008 | US7358386 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 04/15/2008 | US7358376 Substituted Thiophene compounds |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358351 Endothelial cell expression patterns |
| 04/15/2008 | US7358341 Secreted protein for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 04/15/2008 | US7358333 Polypeptides of the IFNα-5 gene |
| 04/15/2008 | US7358329 Antagonists to chaperonin 10 |
| 04/15/2008 | US7358273 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases |
| 04/15/2008 | US7358272 Reduction of levels of tumor necrosis factor-alpha and/or inhibition of phosphodiesterase 4; treating cancer, especially various types of leukemia |
| 04/15/2008 | US7358265 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/15/2008 | US7358261 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 04/15/2008 | US7358253 Indolylmaleimide derivatives |
| 04/15/2008 | US7358252 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever |
| 04/15/2008 | US7358235 Nitrobenzylthioinosine compounds for relief of pain |
| 04/15/2008 | US7358074 Human phosphatase RET31, and variants thereof |
| 04/15/2008 | US7358058 Method and agents for the diagnosis and therapy of chronic inflammatory intestinal disease |
| 04/15/2008 | US7358056 Methods for modulating signal transduction mediated by TGF-β and related proteins |
| 04/15/2008 | US7358054 Crystal structure of the complex between one such antibody and the alpha 1-I domain of VLA-1, and to the use of this structural information for computational drug design |
| 04/15/2008 | US7357924 Nucleic acids/proteins/antibodies/mimetics for cell differentiation/prolilferation control |
| 04/15/2008 | CA2381797C Composition comprising a tramadol material and an anticonvulsant drug |
| 04/15/2008 | CA2171614C Pharmaceutical composition containing sialic acid derivatives |
| 04/15/2008 | CA2154424C 1-phenyl-3-dimethylaminopropane compounds having a pharmaceutical effect |
| 04/10/2008 | WO2008042926A1 Cyclic modulators of chemokine receptor activity |
| 04/10/2008 | WO2008042925A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 04/10/2008 | WO2008042611A2 Method of using il6 antagonists with mitoxantrone for prostate cancer |
| 04/10/2008 | WO2008041751A1 Pharmaceutical preparation for treating fibromyalgia |
| 04/10/2008 | WO2008041236A2 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
| 04/10/2008 | WO2008041219A1 A milk protein composition and use thereof |
| 04/10/2008 | WO2008040547A1 Substituted indeno[1,2-b]indole derivatives as novel inhibitors of protein kinase ck2 and their use as tumour therapeutic agents, cytostatics and diagnostic aids |
| 04/10/2008 | WO2008040087A1 A method of treatment and agents useful for same |
| 04/10/2008 | WO2008017752A3 Eucalyptus extract, method of preparation and therapeutic uses thereof |
| 04/10/2008 | WO2008012361A3 Dimethano-[1,3] dioxocino [6,5-d] pyrimidine-spiro derivatives of tetrodotoxin, process for their synthesis and uses thereof in the treatment of pain |
| 04/10/2008 | WO2008011094A3 Cytokine induction of selectin ligands on cells |
| 04/10/2008 | WO2008005303A3 Thiazolopyrimidine modulators of trpv1 |
| 04/10/2008 | WO2008003702A3 Fused bicyclic compounds interacting with the histamine h4 receptor |
| 04/10/2008 | WO2007149451B1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 04/10/2008 | WO2007121918A3 Use of 2-(purin-9-yl)-tetrahydofuran-3,4-diol derivatives as adenosine a2a receptor agonists |
| 04/10/2008 | WO2007107161A3 Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis |
| 04/10/2008 | WO2007065662A3 Trisubstituted quinazolinone derivatives as vanilloid antagonists |
| 04/10/2008 | US20080086000 Prostaglandin reductase |
| 04/10/2008 | US20080085910 For inflammatory bowel disease; oral administration, bioavailability, pharmacokinetics; 2-(2,6-Dichlorobenzamido)-5-[4-(ethyl-pyrimidin-2-ylamino)phenyl]pent-4-enoic acid methyl ester for example |
| 04/10/2008 | US20080085909 Protein kinase C (PKC); rheumatoid arthritis, lupus, transplant rejection, asthma, inflammatory bowel disease, cancer and diabetes; for example, 2-(pyrrolidin-3-ylmethylamino)-9-(2-trifluoromethoxybenzyl)-7,8-dihydro-9H-purin-8-one |
| 04/10/2008 | US20080085900 Sulfonylguanidine compounds and pharmaceutical uses thereof |
| 04/10/2008 | US20080085898 And 8-substituted 2-(imidazolo[4,5-c]pyridinyl)purines; Janus kinase 3 inhibitors; autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection |
| 04/10/2008 | US20080085891 Asthma and allergic inflammation modulators |
| 04/10/2008 | US20080085884 Eating disorders, psychological disorders, sexual disorders, nervous system disorders, sleep disorders, autism; 4-(Benzyloxy)-6'-[3-methyl-3-(methylamino)pyrrolidin-1-yl]-2H-1,3'-bipyridin-2-one for example |
| 04/10/2008 | US20080085859 Drug Promoting Ceramide Transport, Base Sequence for Producing the Drug, Method of Measuring Activity of Promoting Ceramide Release and Method of Measuring Activity of Promoting Intermembrane Ceramide Transfer |
| 04/10/2008 | US20080085308 Granules Comprising Paracetamol, a Nsaid and a Sugar Alchohol Made by Melt Extrusion |
| 04/10/2008 | US20080085268 Using probiotic microorganisms in the treatment and prevention of gastrointestinal inflammation |
| 04/10/2008 | US20080085244 comparing levels with untreated ovariectomized animal determining amount of an estrogen to reduce amyloid peptides in brain of an animal without affecting soluble APP level; administering test compound to an ovariectomized non-human animal; beta.17-estradiol reversed ovx-associated levels; Alzheimer's |
| 04/10/2008 | CA2665468A1 Substituted indeno[1,2-b]indole derivatives as novel inhibitors of protein kinase ck2 and their use as tumor therapeutic agents, cytostatics and diagnostic aids |
| 04/10/2008 | CA2665141A1 Composition comprising crustacean gastrolith components and its use |
| 04/10/2008 | CA2664621A1 Pyrazine-2-carboxamide derivatives |
| 04/09/2008 | EP1908467A1 Herpesvirus-derived therapeutic agent for pain |
| 04/09/2008 | EP1908460A1 Use of (1R, 2R)-3-(2-dimethyl amino methyl-cyclohexyl) phenol for treating painful inflammations |
| 04/09/2008 | EP1907406A1 Crystalline forms of macrolide compounds endowed with antiinflammatory activity |
| 04/09/2008 | EP1907405A1 Thiocolchicoside analogues with myorelaxant and anti-inflammatory activity |
| 04/09/2008 | EP1907399A1 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands |
| 04/09/2008 | EP1907392A1 Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase |
| 04/09/2008 | EP1907003A2 Combination therapy with inhibitors of hmgb and caspase for the treatment of inflammatory diseases |
| 04/09/2008 | EP1906933A2 Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor |
| 04/09/2008 | EP1660118B1 Method for identification of regulatory tr1 lymphocytes by the presence and overexpression of specific molecules and application thereof |
| 04/09/2008 | EP1439837B1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 04/09/2008 | EP1414444B1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 04/09/2008 | EP1173767B1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 04/09/2008 | EP1140964B1 Connective tissue growth factor (ctgf) fragment |
| 04/09/2008 | EP1058725B1 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
| 04/09/2008 | EP0958287B2 Sulfamide-metalloprotease inhibitors |
| 04/09/2008 | CN101160311A Polymorphic form of 6- (4-chlorophenyl) -2, 2-dimethyl-7-phenyl-2, 3-dihydro-lh-pyrrolizin-5-ylacetic acid |
| 04/09/2008 | CN101160309A Novel imidazo [1, 5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/09/2008 | CN101160305A Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics |
| 04/09/2008 | CN101160285A Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as vr1 receptor antagonists |
| 04/09/2008 | CN101156937A Medicine wine for curing rheumatism, gout and hydrocele disease |
| 04/09/2008 | CN101156920A Oral administration externally used drug for treating traumatic injury and its preparation method |